000			03205nam a22004335i 4500
001			85951
003			ES-MaUEC
005			20230207040535.0
007			cr nn 008mamaa
008			160727s2016 gw | s |||| 0|eng d
020			_a9783319327945
040			_aES-MaUEC
050		4	_aRC776.F5 _b2016 EB
082	0	4	_a616.2
090			_aRC776.F5 _bN384 2016
100	1		_aNathan, Steven D. _988397 _0Local
245	1	0	_aGuide to Clinical Management of Idiopathic Pulmonary Fibrosis _cby Steven D Nathan, A Whitney Brown, Christopher S King
260			_aCham _bSpringer International Publishing _bImprint _bAdis _c2016
300			_a1 recurso en línea (XVII, 123 p.) _b18 ilustraciones, 12 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aOverview of idiopathic pulmonary fibrosis -- Clinical presentation and diagnosis -- Diseases that mimic idiopathic pulmonary fibrosis -- Pathogenesis idiopathic pulmonary fibrosis -- Prognosis, clinical course, and monitoring of patients with idiopathic pulmonary fibrosis -- Comorbidities and complications of idiopathic pulmonary fibrosis -- Treatment of idiopathic pulmonary fibrosis -- Non-pharmacologic management of idiopathic pulmonary fibrosis -- The future of idiopathic pulmonary fibrosis.
520			_aThis clinically focused pocket guide offers a concise yet complete overview of idiopathic pulmonary fibrosis, covering the most recent information on aspects such as pathophysiology, management, treatment, and clinical trials. The text is easily accessible and offers pulmonologists and other health care professionals with an excellent quick reference tool. Full color images and figures enhance and summarize key aspects of the text. Idiopathic pulmonary fibrosis is a condition that affects the alveoli and leads to serious lung damage, and the idiopathic nature of this disease means that the origin or cause is unknown. This disease is relatively rare, affecting 3 in 10,000 people, but it is becoming more common. Physicians should be aware of the early stages and symptoms of this disease so management strategies can be implemented quickly, and the best treatment can be administered.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650	0	7	_aAparato respiratorio _0LocalX _2embne _9138569
650	1	7	_aSalud pública _0LocalX _2embne _9138408
650	0	7	_aSalud pública _0LocalX _2embne _9138408
700	1		_aBrown, A. Whitney _0Local _999296
700	1		_aKing, Christopher S. _999297 _0Local
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-32794-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319327945
907			_a.b12952291 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC776.F5 N384 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11614699 _z30-06-17
999			_c85951 _d85951 _x1